Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/5272
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wachira, Juddy | - |
dc.contributor.author | Kimaiyo, Sylvester | - |
dc.contributor.author | Omodi, Victor | - |
dc.date.accessioned | 2021-09-29T11:37:17Z | - |
dc.date.available | 2021-09-29T11:37:17Z | - |
dc.date.issued | 2021 | - |
dc.identifier.uri | https://journals.lww.com/aidsonline/Abstract/2021/10010/Microfinance,_retention_in_care,_and_mortality.12.aspx | - |
dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/5272 | - |
dc.description.abstract | Objective: To measure associations between participation in community-based microfinance groups, retention in HIV care, and death among people with HIV (PWH) in low-resource settings. Design and methods: We prospectively analyzed data from 3609 patients enrolled in an HIV care program in western Kenya. HIV patients who were eligible and chose to participate in a Group Integrated Savings for Health Empowerment (GISHE) microfinance group were matched 1 : 2 on age, sex, year of enrollment in HIV care, and location of initial HIV clinic visit to patients not participating in GISHE. Follow-up data were abstracted from medical records from January 2018 through February 2020. Logistic regression analysis examined associations between GISHE participation and two outcomes: retention in HIV care (i.e. >1 HIV care visit attended within 6 months prior to the end of follow-up) and death. Socioeconomic factors associated with HIV outcomes were included in adjusted models. Results: The study population was majority women (78.3%) with a median age of 37.4 years. Microfinance group participants were more likely to be retained in care relative to HIV patients not participating in a microfinance group [adjusted odds ratio (aOR) = 1.31, 95% confidence interval (CI) 1.01–1.71; P = 0.046]. Participation in group microfinance was associated with a reduced odds of death during the follow-up period (aOR = 0.57, 95% CI 0.28–1.09; P = 0.105). Conclusion: Participation in group-based microfinance appears to be associated with better HIV treatment outcomes. A randomized trial is needed to assess whether microfinance groups can improve clinical and socioeconomic outcomes among PWH in similar settings. | en_US |
dc.language.iso | en | en_US |
dc.subject | Microfinance | en_US |
dc.subject | Mortality | en_US |
dc.title | Microfinance, retention in care, and mortality among patients enrolled in HIV care in East Africa | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.